ArticleAmerican journal of respiratory and critical care medicine2024
Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.
Open access · greenAbstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
14.2field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.
- Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement.American journal of respiratory and critical care medicine · 2025Guideline
- A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial.Nature medicine · 2025Trial
- Bexotegrast Shows Dose-Dependent Integrin αAnnals of the American Thoracic Society · 2025Trial
- Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial.American journal of respiratory and critical care medicine · 2024Trial
- Meaningful thresholds for change in quantitative computed tomography-derived fibrosis extent in idiopathic pulmonary fibrosis.American journal of respiratory and critical care medicine · 2026Article
- Urinary Collagen Peptides Predict Mortality.Proteomics · 2026Article
- A Nomogram Model for Early Mortality Risk Stratification in Elderly Patients with Idiopathic Pulmonary Fibrosis: An Integrative Analysis of Serum Biomarkers and Pulmonary Function Parameters.Journal of clinical medicine · 2026Article
- Lung fibroblasts contribute to release of serum amyloid A as potential biomarker of exacerbation of lung fibrosis in mice.ERJ open research · 2026Article
- Transcriptomic profiling of collagen gene expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2026Article
- Latent transforming growth factor binding protein-2 (LTBP2), an IPF biomarker of clinical decline, promotes TGF-beta signaling and lung fibrosis in mice.American journal of respiratory cell and molecular biology · 2026Article
- Review
- Clinical peptidomics for respiratory diseases: matrices, workflows, and translation towards treatable traits, with a focus on COPD.Clinical proteomics · 2026Review
- Molecular endotypes predict differential response to immunosuppressant therapy in non-idiopathic pulmonary fibrosis interstitial lung disease.American journal of respiratory and critical care medicine · 2026Observational
- A multi-omics framework for survival mediation analysis of high-dimensional proteogenomic data.PLoS computational biology · 2026Article
- Expression of complement pathway genes is associated with progression of idiopathic pulmonary fibrosis.Respiratory research · 2026Article
- Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies.Signal transduction and targeted therapy · 2026Review
- Plasma proteomic and machine learning models for differentiating idiopathic pulmonary fibrosis and connective tissue disease-associated interstitial lung disease: findings from a prospective cohort.Respiratory research · 2026Article
- Prioritizing Therapeutic Targets for Interstitial Lung Disease: A Causal Mediation Analysis.Research square · 2026Article
- Circulating biomarkers in subjects with progressive pulmonary fibrosis: data from the INBUILD trial.ERJ open research · 2026Article
- Immunosenescence in Idiopathic Pulmonary Fibrosis.Journal of inflammation research · 2026Review
Corrections and comments
- Commented on by
Authors and funding
21 authors at 7 institutions in 1 country.
Justin M OldhamDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine.ORCID 0000-0003-4957-8869
Yong HuangDivision of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, Virginia.
Swaraj BoseDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan.
Shwu-Fan MaDivision of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, Virginia.
John S KimDivision of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, Virginia.
Alexandra SchwabDivision of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, Virginia.
Christopher TingDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine.
Kaniz MouDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine.
Cathryn T LeeSection of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois.
Ayodeji AdegunsoyeSection of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois.
Sahand GhodratiDivision of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis, Davis, California.
Janelle Vu PugashettiDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine.
Nazanin NazemiDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine.
Mary E StrekSection of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois.
Angela L LinderholmDivision of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis, Davis, California.
Ching-Hsien ChenDivision of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis, Davis, California.ORCID 0000-0002-4211-9988
Susan MurrayDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan.
Rachel L ZemansDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine.
Kevin R FlahertyDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine.
Fernando J MartinezWeill Cornell Medical Center, New York, New York.
Imre NothDivision of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, Virginia.
Michigan United · USUniversity of Virginia · USUniversity of California, Davis · USUniversity of Chicago · USUniversity of Michigan · USCornell University · USPulmonary and Critical Care Associates · US
Funding
PULMONARY CELLULAR AND MOLECULAR BIOLOGY TRAININGT32HL007749 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Robert Pickett Dickson · 1993 to 2026
$19.9MRESEARCH TRAINING IN RESPIRATORY BIOLOGYT32HL007605 · NHLBI · UNIVERSITY OF CHICAGO · PI Yun Fang, Gokhan M. Mutlu · 1985 to 2026
$18.1M1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases studyUH3HL145266 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MARTINEZ, FERNANDO J, NOTH, IMRE · 2021 to 2025
$11.6MMechanisms of Alveolar Homeostasis, Injury, Regeneration, and FibrosisR35HL160770 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Rachel Lynne Zemans · 2022 to 2026
$4.3MArchitectural structure and regulation of TOLLIP in IPFR01HL130796 · NHLBI · UNIVERSITY OF VIRGINIA · PI NOTH, IMRE · 2016 to 2019
$3.1MProteomic Profiling of Idiopathic Pulmonary Fibrosis Progression TrajectoryR01HL169166 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Justin M Oldham · 2023 to 2026
$2.7MRole of TGFβ/BMP Antagonism in Regeneration of the Alveolar Epithelium After Lung InjuryR01HL147920 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ZEMANS, RACHEL LYNNE · 2020 to 2021
$992k1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases studyUG3HL145266 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MARTINEZ, FERNANDO J, NOTH, IMRE · 2019 to 2019
$977kRole of polyunsaturated fatty acids in pulmonary fibrosisK23HL150301 · NHLBI · UNIVERSITY OF VIRGINIA · PI KIM, JOHN S · 2021 to 2025
$858kImproving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic ClustersK23HL146942 · NHLBI · UNIVERSITY OF CHICAGO · PI ADEGUNSOYE, AYODEJI · 2020 to 2024
$810kRegulation and Mechanisms of Transitional Epithelial Cell Senescence in Lung FibrosisF32HL172379 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TING, CHRISTOPHER · 2024 to 2025
$130kNHLBI NIH HHS F32 HL172379NHLBI NIH HHS K23 HL146942NHLBI NIH HHS K23HL146942NHLBI NIH HHS K23 HL150301NHLBI NIH HHS K23HL150301NHLBI NIH HHS R01 HL130796NHLBI NIH HHS R01 HL147920NHLBI NIH HHS R01 HL169166NHLBI NIH HHS R35 HL160770NHLBI NIH HHS R35HL160770NHLBI NIH HHS RO1HL130796NHLBI NIH HHS T32 HL007605NHLBI NIH HHS T32HL007605NHLBI NIH HHS T32 HL007749NHLBI NIH HHS T32HL007749NHLBI NIH HHS UG3 HL145266NHLBI NIH HHS UG3HL145266NHLBI NIH HHS UH3 HL145266
Abstract
PubMed holds no abstract for this paper.
Indexed as
BiomarkersIdiopathic Pulmonary FibrosisProteomicsAgedCohort StudiesFemaleHumansMaleMiddle AgedPrognosisProportional Hazards ModelsProspective StudiesBiomarkersinterstitial lung diseaseIPFproteomicssurvivaltransplant
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.